Megan M Lantry

Title: Megan M. Lantry: Innovator in Dimeric Fusion Proteins

Introduction

Megan M. Lantry is a notable inventor based in Redmond, WA (US). She has made significant contributions to the field of biotechnology, particularly in the development of dimeric fusion proteins. Her work has implications for therapy, diagnosis, and research.

Latest Patents

Megan holds a patent for "Dimeric fusion proteins and related compositions and methods." This patent discloses compositions and methods relating to soluble dimeric proteins. The dimeric proteins consist of first and second polypeptide fusions linked via a dimerizing domain. Each polypeptide fusion comprises first and second monomer domains corresponding to a cytokine or an extracellular domain of a cell-surface receptor. The positioning of the monomer domains can vary, either amino terminal and carboxyl terminal to the dimerizing domain or in tandem. These dimeric proteins are valuable in various applications, including therapeutic and diagnostic methods.

Career Highlights

Megan is currently associated with Zymogenetics, Inc., where she continues to advance her research and innovations. Her work has led to the development of groundbreaking technologies in the field of protein engineering.

Collaborations

Megan has collaborated with esteemed colleagues such as Steven D. Levin and Margaret Dow Moore. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Megan M. Lantry's contributions to the field of dimeric fusion proteins exemplify her dedication to advancing biotechnology. Her innovative work continues to impact therapeutic and diagnostic applications significantly.